Boston Scientific Corp
Close on Nov 18, 2026Market cap $63.24BP/E 17.7Yield –
Boston Scientific NIH ClinicalTrials.gov by Quarter
NIH ClinicalTrials.gov — Boston Scientific Studies Started in Period (studies)
Boston Scientific NIH ClinicalTrials.gov: 11.00 studies in Q3 2026, up 37.5% from a year earlier.
Where the Q3 2026 figure comes from
Source: NIH ClinicalTrials.gov Registry — Boston Scientific ↗
Reported in U.S. National Library of Medicine (ClinicalTrials.gov API v2 — Boston Scientific Sponsored Studies).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up NIH ClinicalTrials.gov
- NIH ClinicalTrials.gov — Cumulative Boston Scientific Studies Registered (studies)–
- NIH ClinicalTrials.gov — Interventional Device Trials Started (studies)–
- NIH ClinicalTrials.gov — Observational Registries & Post-Market Studies Started (studies)–
- NIH ClinicalTrials.gov — Target Patient Enrollment in Newly Started BSX Studies (patients)–
Cite this data
StockData. (2026). Boston Scientific NIH ClinicalTrials.gov, quarterly Q1 2015–Q3 2026 [Data set]. Compiled from Boston Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/bsx/kpis/ext-ct-started
See every metric in the Boston Scientific KPI table. Data updated Nov 4, 2026.
See a number that looks wrong?